Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.

Name: Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.
Author: Zhu, Cheng-Ying

Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. — المؤلف: Zhu, Cheng-Ying — Annals of transplantation 20190822

المؤلف: Zhu, Cheng-Ying
النشر: Annals of transplantation 20190822
الوصف: 175-184 p.
الموضوعات: Adolescent؛ Adult؛ Antineoplastic Agents, Immunological؛ Child؛ DNA, Viral؛ Epstein-Barr Virus Infections؛ Female؛ Hematopoietic Stem Cell Transplantation